Fda safety communication does not impact bd syringes

Company committed to support u.s. health care needs franklin lakes, n.j. , nov. 30, 2023 /prnewswire/ -- bd (becton, dickinson and company) (nyse: bdx), a leading global medical technology company, today issued the following statement regarding the u.s. food and drug administration (fda) safety communication on evaluation of certain plastic syringes: eric borin, president of bd medication delivery solutions said, "the fda safety notice does not apply to any bd syringes.
BDX Ratings Summary
BDX Quant Ranking